Inhibition of N-diethylnitrosamine metabolism by human lung cancer cell lines with features of well differentiated pulmonary endocrine cells

Tibor J. Hegedus, Miriam Falzon, Nadine Margaretten, Adi F. Gazdar, Hildegard M. Schuller

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Cell lines derived from a human pulmonary carcinoid tumor (NCI-H727) and from a human pulmonary large cell carcinoma (NCI-H460) were investigated by transmission electron microscopy. Both cell lines, at early in vitro passage, demonstrated ultrastructural features of well differentiated pulmonary endocrine cells. Line NCI-H727 had more endoplasmic reticulum than line NCI-H460 and demonstrated l-dopa decarboxylase activity as well as production of calcitonin and bombesin. Because of their ultrastructural resemblance with normal pulmonary endocrine cells, these cell lines were used to test the theory derived from experiments in hamsters that human pulmonary endocrine cells can metabolize N-nitrosodiethylamine (DEN). The cells were incubated in vitro with [14C]DEN. Metabolism was assessed by 14CO2 production. Both cell lines metabolized DEN to a much greater extent than previously investigated human lung cancer cell lines of Clara cell and alveolar type II cell morphology. In keeping with its abundant endoplasmic reticulum, line NCI-H727 yielded 14CO2 in the 300 nM range, whereas NCI-H460 was less active. Metabolism was time dependent. Preincubation with various enzyme inhibitors yielded a highly significant inhibition of DEN metabolism with the two inhibitors of the fatty acid cyclooxygenase component of prostaglandin endoperoxide synthetase, aspirin and indomethacin. Inhibitors of cytochrome P-450 (CO, piperoxylbutoxide) did not inhibit DEN metabolism. Preincubation with sinigrin yielded similar negative results as CO and piperonylbutoxide. Our data are in support of the theory that human pulmonary endocrine cells can metabolize nitrosamines. Moreover, the experiments with enzyme inhibitors suggest that in this cell type such metabolism is largely dependent on prostaglandin endoperoxide synthetase.

Original languageEnglish (US)
Pages (from-to)3339-3343
Number of pages5
JournalBiochemical Pharmacology
Volume36
Issue number20
DOIs
StatePublished - Oct 15 1987
Externally publishedYes

Fingerprint

Enzyme inhibition
Diethylnitrosamine
Endocrine Cells
Metabolism
Lung Neoplasms
Cells
Cell Line
Lung
Prostaglandin-Endoperoxide Synthases
Enzyme Inhibitors
Carbon Monoxide
Endoplasmic Reticulum
Dopa Decarboxylase
Alveolar Epithelial Cells
Large Cell Carcinoma
Bombesin
Nitrosamines
Carcinoid Tumor
Calcitonin
Transmission Electron Microscopy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Inhibition of N-diethylnitrosamine metabolism by human lung cancer cell lines with features of well differentiated pulmonary endocrine cells. / Hegedus, Tibor J.; Falzon, Miriam; Margaretten, Nadine; Gazdar, Adi F.; Schuller, Hildegard M.

In: Biochemical Pharmacology, Vol. 36, No. 20, 15.10.1987, p. 3339-3343.

Research output: Contribution to journalArticle

Hegedus, Tibor J. ; Falzon, Miriam ; Margaretten, Nadine ; Gazdar, Adi F. ; Schuller, Hildegard M. / Inhibition of N-diethylnitrosamine metabolism by human lung cancer cell lines with features of well differentiated pulmonary endocrine cells. In: Biochemical Pharmacology. 1987 ; Vol. 36, No. 20. pp. 3339-3343.
@article{a65d54e40e584c95bbc72c3db8bde6ef,
title = "Inhibition of N-diethylnitrosamine metabolism by human lung cancer cell lines with features of well differentiated pulmonary endocrine cells",
abstract = "Cell lines derived from a human pulmonary carcinoid tumor (NCI-H727) and from a human pulmonary large cell carcinoma (NCI-H460) were investigated by transmission electron microscopy. Both cell lines, at early in vitro passage, demonstrated ultrastructural features of well differentiated pulmonary endocrine cells. Line NCI-H727 had more endoplasmic reticulum than line NCI-H460 and demonstrated l-dopa decarboxylase activity as well as production of calcitonin and bombesin. Because of their ultrastructural resemblance with normal pulmonary endocrine cells, these cell lines were used to test the theory derived from experiments in hamsters that human pulmonary endocrine cells can metabolize N-nitrosodiethylamine (DEN). The cells were incubated in vitro with [14C]DEN. Metabolism was assessed by 14CO2 production. Both cell lines metabolized DEN to a much greater extent than previously investigated human lung cancer cell lines of Clara cell and alveolar type II cell morphology. In keeping with its abundant endoplasmic reticulum, line NCI-H727 yielded 14CO2 in the 300 nM range, whereas NCI-H460 was less active. Metabolism was time dependent. Preincubation with various enzyme inhibitors yielded a highly significant inhibition of DEN metabolism with the two inhibitors of the fatty acid cyclooxygenase component of prostaglandin endoperoxide synthetase, aspirin and indomethacin. Inhibitors of cytochrome P-450 (CO, piperoxylbutoxide) did not inhibit DEN metabolism. Preincubation with sinigrin yielded similar negative results as CO and piperonylbutoxide. Our data are in support of the theory that human pulmonary endocrine cells can metabolize nitrosamines. Moreover, the experiments with enzyme inhibitors suggest that in this cell type such metabolism is largely dependent on prostaglandin endoperoxide synthetase.",
author = "Hegedus, {Tibor J.} and Miriam Falzon and Nadine Margaretten and Gazdar, {Adi F.} and Schuller, {Hildegard M.}",
year = "1987",
month = "10",
day = "15",
doi = "10.1016/0006-2952(87)90308-X",
language = "English (US)",
volume = "36",
pages = "3339--3343",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "20",

}

TY - JOUR

T1 - Inhibition of N-diethylnitrosamine metabolism by human lung cancer cell lines with features of well differentiated pulmonary endocrine cells

AU - Hegedus, Tibor J.

AU - Falzon, Miriam

AU - Margaretten, Nadine

AU - Gazdar, Adi F.

AU - Schuller, Hildegard M.

PY - 1987/10/15

Y1 - 1987/10/15

N2 - Cell lines derived from a human pulmonary carcinoid tumor (NCI-H727) and from a human pulmonary large cell carcinoma (NCI-H460) were investigated by transmission electron microscopy. Both cell lines, at early in vitro passage, demonstrated ultrastructural features of well differentiated pulmonary endocrine cells. Line NCI-H727 had more endoplasmic reticulum than line NCI-H460 and demonstrated l-dopa decarboxylase activity as well as production of calcitonin and bombesin. Because of their ultrastructural resemblance with normal pulmonary endocrine cells, these cell lines were used to test the theory derived from experiments in hamsters that human pulmonary endocrine cells can metabolize N-nitrosodiethylamine (DEN). The cells were incubated in vitro with [14C]DEN. Metabolism was assessed by 14CO2 production. Both cell lines metabolized DEN to a much greater extent than previously investigated human lung cancer cell lines of Clara cell and alveolar type II cell morphology. In keeping with its abundant endoplasmic reticulum, line NCI-H727 yielded 14CO2 in the 300 nM range, whereas NCI-H460 was less active. Metabolism was time dependent. Preincubation with various enzyme inhibitors yielded a highly significant inhibition of DEN metabolism with the two inhibitors of the fatty acid cyclooxygenase component of prostaglandin endoperoxide synthetase, aspirin and indomethacin. Inhibitors of cytochrome P-450 (CO, piperoxylbutoxide) did not inhibit DEN metabolism. Preincubation with sinigrin yielded similar negative results as CO and piperonylbutoxide. Our data are in support of the theory that human pulmonary endocrine cells can metabolize nitrosamines. Moreover, the experiments with enzyme inhibitors suggest that in this cell type such metabolism is largely dependent on prostaglandin endoperoxide synthetase.

AB - Cell lines derived from a human pulmonary carcinoid tumor (NCI-H727) and from a human pulmonary large cell carcinoma (NCI-H460) were investigated by transmission electron microscopy. Both cell lines, at early in vitro passage, demonstrated ultrastructural features of well differentiated pulmonary endocrine cells. Line NCI-H727 had more endoplasmic reticulum than line NCI-H460 and demonstrated l-dopa decarboxylase activity as well as production of calcitonin and bombesin. Because of their ultrastructural resemblance with normal pulmonary endocrine cells, these cell lines were used to test the theory derived from experiments in hamsters that human pulmonary endocrine cells can metabolize N-nitrosodiethylamine (DEN). The cells were incubated in vitro with [14C]DEN. Metabolism was assessed by 14CO2 production. Both cell lines metabolized DEN to a much greater extent than previously investigated human lung cancer cell lines of Clara cell and alveolar type II cell morphology. In keeping with its abundant endoplasmic reticulum, line NCI-H727 yielded 14CO2 in the 300 nM range, whereas NCI-H460 was less active. Metabolism was time dependent. Preincubation with various enzyme inhibitors yielded a highly significant inhibition of DEN metabolism with the two inhibitors of the fatty acid cyclooxygenase component of prostaglandin endoperoxide synthetase, aspirin and indomethacin. Inhibitors of cytochrome P-450 (CO, piperoxylbutoxide) did not inhibit DEN metabolism. Preincubation with sinigrin yielded similar negative results as CO and piperonylbutoxide. Our data are in support of the theory that human pulmonary endocrine cells can metabolize nitrosamines. Moreover, the experiments with enzyme inhibitors suggest that in this cell type such metabolism is largely dependent on prostaglandin endoperoxide synthetase.

UR - http://www.scopus.com/inward/record.url?scp=0023515154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023515154&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(87)90308-X

DO - 10.1016/0006-2952(87)90308-X

M3 - Article

C2 - 2823818

AN - SCOPUS:0023515154

VL - 36

SP - 3339

EP - 3343

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 20

ER -